The oncology space is one of the largest hotbeds for drug development and innovation, and in the past few decades, a spate of new and effective cancer therapies have come to market. While these treatments are often extremely powerful and can be life-saving, they aren’t without their downsides. Many of them cause adverse reactions and […]

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Editor in the Journal of Diabetes Science and Technology. The study is titled “Digital Therapeutics for Type 2 Diabetes: Incorporating Coaching Support and Validating Digital Monitoring.” People living with Type […]

RNA cell therapy is a new class of advanced therapies now in clinical trials to treat an array of diseases in and beyond oncology. These therapies combine the best features of two therapeutics modalities, conventional RNA therapy and cell therapy, while avoiding key drawbacks. With RNA cell therapy, there is no need to package RNA […]